Journals
Topics
Contributed Content
October 17, 2017
Latest News
October 18, 2017 | Mary Caffrey
The injectible drug is expected to compete with Eli Lilly's Trulicity after a head-to-head trial showed superior results on glycemic control and weight loss.
October 18, 2017 | Surabhi Dangi-Garimella, PhD
The 2-year follow up results from the Keynote-024 trial were presented at the 18th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Yokohama, Japan.
October 18, 2017 | Christina Mattina
In light of recent guidance from the FDA on appropriate communications between payers and drug manufacturers prior to a drug’s approval, a panel of stakeholders at the Academy of Managed Care Pharmacy 2017 Nexus meeting, discussed how these new guidelines can raise as many questions as they answer.
October 18, 2017 | Jaime Rosenberg
There is a relationship between CD8+ tumor infiltrating lymphocytes (TILs) and high-grade serous ovarian carcinoma (HGSOC) survival, according to a new study published in JAMA Oncology.
October 18, 2017 | Alison Rodriguez
Patients with chronic obstructive pulmonary disease (COPD) often require complex medication regimens that are associated with significant disease severity, comorbidities, and multidimensional indices, according to a study.
October 18, 2017 | Kelly Davio
In a recent JAMA Viewpoint, Andrew Kolondy, MD, and Thomas R. Frieden, MD, MPH, called on the US federal government to take 10 steps to address the problem of opioid addiction.
October 18, 2017 | Alison Rodriguez
Authors of dermatology clinical practice guidelines (CPGs) may be receiving significant industry payments that are not fully disclosed—suggesting that the American Academy of Dermatology (AAD) policies may benefit from stronger enforcement or the development of new standards.
October 18, 2017 | Laura Joszt
History of neutropenia with methotrexate, concurrent treatment with synthetic disease-modifying antirheumatic drugs (sDMARDs), and tocilizumab were risk factors for developing neutropenia while on biologic DMARDs (bDMARDs), according to a study published in The Journal of Rheumatology.
October 18, 2017 |
The COMPASS trial results could reshape the standard of care for patients with coronary artery disease (CAD) and peripheral artery disease (PAD), according to Deepak Bhatt, MD, MPH, of Brigham and Women's Hospital and Harvard Medical School.
October 18, 2017 | AJMC Staff
October 18, 2017 | Christina Mattina
Experts from Express Scripts discussed how data on consumer behavior can be used to improve health outcomes and control the costs of care during a session of the Academy of Managed Care Pharmacy 2017 Nexus meeting.
October 17, 2017 | Christina Mattina
A session at the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus meeting discussed the implications of recent legislative and regulatory changes in healthcare at the federal and state levels.
October 17, 2017 | Christina Mattina
Aimee Tharaldson, PharmD, of Express Scripts kicked off the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus, held October 16-19 in Dallas, Texas, with a presentation on the pipeline of specialty pharmaceuticals in development.
October 17, 2017 | Kelly Davio
A new study suggests that ultrasound technology could allow for the earlier detection of inflammation, and therefore earlier treatment of inflammatory diseases, in patients with early joint pain.
From the Journals
Bailey and Newton
Nubla et al
An in-depth look into a nationwide collaborative initiative to standardize and improve oncology dispensing practices for the benefit of patient/provider education, adherence, and overall care.
Clough et al
The authors used Medicare claims data to examine trends in hospital–physician integration in high-volume specialties, including medical oncology.
Cuellar et al
Financial incentives created under the Affordable Care Act can help promote employer wellness programs and support preventive services utilization.
Ehlers et al
Understanding the relationships among patient-reported outcomes, satisfaction, and quality is the first step in drawing meaningful conclusions that can then be translated into policy.
Shank et al
With the clinical and financial implications of high-cost medications, and their impact on health system revenue, it is of utmost importance for all key stakeholders to be engaged in the complex revenue cycle.
Leber
The hospital formulary system is an ongoing process that evaluates and selects the safest, most effective, and most economical care for hospitalized patients. As healthcare continues to change, so will the formulary management process.
Sharp et al
Antibiotics are not required to achieve high patient satisfaction. Patient age, chronic conditions, and an established patient–provider relationship influence satisfaction with acute care.
Produced by Laura Joszt and The Center for Biosimilars®
AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.
Compendia
Know Your News
Formulary
Upcoming Partner Events
Most Popular
Interviews View More Interviews >>
AJMC Strategic Alliance
